GlobalRPh Renal Dosing Masterv7.4
Renal Dosing Master: fast drug lookup
Source review / handoff

Tolterodine (Detrol)

One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.

Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.

Share or print this source review

1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.

Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.

Clinical context remains essential

Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.

Check source scope before reading a dose

Detrol - labeled renal guidance

Product / population
Tolterodine tartrate (Detrol), oral tablet
Renal method
Renal impairment categories as defined by the cited product label
Source revision
DailyMed SPL version 5, posted Feb 03, 2025
Retrieved
2026-11-07
Local review status
Selected renal passages reviewed; independent clinician adjudication pending.

Documented differences and cautions on this drug

All record notes are retained here, including notes about sources not selected in this review.

Detrol - product and source limitations

Verify immediate-release tablets. The ER capsule has different dosing instructions.

What to reconcile: Apply only to the stated formulation, indication and renal population.

Selected renal passages reviewed; independent clinician adjudication pending.

Open this note and its source references
Official

Detrol - labeled renal guidance

Open original reference

DailyMed / product prescribing information · Tolterodine tartrate (Detrol), oral tablet

Renal method: Renal impairment categories as defined by the cited product label
Source date: DailyMed SPL version 5, posted Feb 03, 2025
Retrieved: 2026-11-07

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

Selected renal passages reviewed; independent clinician adjudication pending.

Renal guidance: Renal Insufficiency

For significant renal impairment the immediate-release tolterodine regimen is 1 mg twice daily. Verify immediate-release tablets. The ER capsule has different dosing instructions.

RDM74-detrol-official-1 · Source locator: Renal guidance: Renal Insufficiency

Source identity and provenance
Source family
product_label
Source
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=41eb00d2-64e3-4ec9-8732-4bfc81b04180
Retrieved
2026-11-07
Renal-function method
Renal impairment categories as defined by the cited product label
Source date/version
DailyMed SPL version 5, posted Feb 03, 2025
Hash meaning
SHA-256 of the local selected-source summary
Local summary SHA-256
1c4cd13993a5de530bf15ca65f4aa2ba21739fcf9654b6e81233f771641ac14e

Document the clinical decision separately

This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.

GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.

Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=general-tolterodine&s1=RDM74-detrol-official&h1=da46990e45d95055cf1165c6fb39c5f2251ba14d7a91ab6d5179bd12ab3c3b09

Top